BlackRock Fund Advisors’s Allergan plc AGN.PRA Stock Holding History

BlackRock Fund Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$400M	Sell	524,084 -1,943	-0.4%	-$1.47M	0.07%	269
2016 Q3	$432M	Buy	526,027 +40,352	+8%	+$34.9M	0.09%	223
2016 Q2	$405M	Buy	485,675 +49,032	+11%	+$41M	0.09%	216
2016 Q1	$401M	Buy	436,643 +7,656	+2%	+$7.32M	0.09%	207
2015 Q4	$441M	Buy	428,987 +22,504	+6%	+$22.6M	0.1%	182
2015 Q3	$384M	Buy	+406,483	New	+$424M	0.1%	194

Other funds holding AGN.PRA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock Fund Advisors's AGN.PRA Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Allergan plc (AGN.PRA) stake by 0.37% in Q4 2016, selling an estimated $1.47M and leaving 524,084 shares worth $400M. The position accounts for 0.07% of the portfolio, ranked #269.

BlackRock Fund Advisors first reported a position in AGN.PRA in Q3 2015 and has held it in 6 quarters since. The position peaked at $441M in Q4 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

BlackRock Fund Advisors held 524,084 shares of Allergan plc worth $400M as of Q4 2016.
BlackRock Fund Advisors sold 1,943 Allergan plc shares in Q4 2016, an estimated $1.47M.
Allergan plc made up 0.07% of BlackRock Fund Advisors's portfolio in Q4 2016, its #269 holding.
BlackRock Fund Advisors first reported a position in Allergan plc in Q3 2015 and has held it in 6 quarters since.
BlackRock Fund Advisors's Allergan plc position peaked at $441M in Q4 2015.
108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.